James A. Schoeneck's most recent trade in FibroGen Inc was a trade of 23,567 Common Stock done at an average price of $5.1 . Disclosure was reported to the exchange on June 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| FibroGen Inc | James A. Schoeneck | Director | Purchase of securities on an exchange or from another person at price $ 5.07 per share. | 30 Jun 2025 | 23,567 | 39,666 (0%) | 0% | 5.1 | 119,485 | Common Stock |
| FibroGen Inc | James A. Schoeneck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 120,000 | 120,000 | - | - | Stock Option (Right to Buy) | |
| FibroGen Inc | James A. Schoeneck | Director | Purchase of securities on an exchange or from another person at price $ 0.35 per share. | 20 Mar 2025 | 250,000 | 323,722 (0%) | 0% | 0.4 | 88,000 | Common Stock |
| FibroGen Inc | James A. Schoeneck | Director | Purchase of securities on an exchange or from another person at price $ 0.34 per share. | 20 Mar 2025 | 50,000 | 373,722 (0%) | 0% | 0.3 | 17,040 | Common Stock |
| FibroGen Inc | James A. Schoeneck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 70,000 | 70,000 | - | - | Stock Option (Right to Buy) | |
| FibroGen Inc | James A. Schoeneck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2023 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| FibroGen Inc | James A. Schoeneck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 12,666 | 12,666 | - | - | Stock Option (Right to Buy) | |
| FibroGen Inc | James A. Schoeneck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 8,289 | 28,766 (0%) | 0% | 0 | Common Stock | |
| FibroGen Inc | James A. Schoeneck | Director | Sale of securities on an exchange or to another person at price $ 18.03 per share. | 07 Jun 2023 | 7,100 | 73,722 (0%) | 0% | 18.0 | 127,987 | Common Stock |
| FibroGen Inc | James A. Schoeneck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 25,684 | 25,684 | - | - | Stock Option (Right to Buy) | |
| FibroGen Inc | James A. Schoeneck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 15,777 | 20,477 (0%) | 0% | 0 | Common Stock | |
| FibroGen Inc | James A. Schoeneck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 7,800 | 7,800 | - | - | Stock Option (Right to Buy) | |
| FibroGen Inc | James A. Schoeneck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 4,700 | 14,100 (0%) | 0% | 0 | Common Stock | |
| FibroGen Inc | James A. Schoeneck | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2021 | 6,000 | 0 | - | - | Stock Option (Right to Buy) | |
| FibroGen Inc | James A. Schoeneck | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.78 per share. | 04 Jan 2021 | 6,000 | 15,400 (0%) | 0% | 9.8 | 58,650 | Common Stock |